Cure enters the BO3 with strong recent form as a top Terran, posting a 2–0 group record and 4–1 map score in the 2026 GSL Season 2 Group A while advancing from prior stages. Classic, a Protoss contender, sits at 1–2 with a 3–5 map record, showing vulnerability in recent series losses. Head-to-head results favor Cure, including a 2–0 sweep in Season 1 Group Stage and a 2–1 win in the current cycle. Map pool factors such as 10000 Feet LE and Winter Madness LE, combined with Cure’s positioning and macro execution against Protoss aggression, shape the matchup. The best-of-three format rewards consistent opening execution and adaptation in this high-stakes group environment.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日Cure vs Classic
Moneyline
$0 Vol.
Map 1 Winner
$0 Vol.
Map Handicap
$0 Vol.
Total Games
$0 Vol.
This market will resolve to "Cure" if Cure win the match against Classic.
This market will resolve to "Classic" if Classic win the match against Cure.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://liquipedia.net/starcraft2/Main_Page. However, if https://liquipedia.net/starcraft2/Main_Page has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.
マーケット開始日: May 27, 2026, 8:30 AM ET
Cure vs Classic
Moneyline
$0 Vol.
Map 1 Winner
$0 Vol.
Map Handicap
$0 Vol.
Total Games
$0 Vol.
This market will resolve to "Cure" if Cure win the match against Classic.
This market will resolve to "Classic" if Classic win the match against Cure.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://liquipedia.net/starcraft2/Main_Page. However, if https://liquipedia.net/starcraft2/Main_Page has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.
マーケット開始日: May 27, 2026, 8:30 AM ET
Cure enters the BO3 with strong recent form as a top Terran, posting a 2–0 group record and 4–1 map score in the 2026 GSL Season 2 Group A while advancing from prior stages. Classic, a Protoss contender, sits at 1–2 with a 3–5 map record, showing vulnerability in recent series losses. Head-to-head results favor Cure, including a 2–0 sweep in Season 1 Group Stage and a 2–1 win in the current cycle. Map pool factors such as 10000 Feet LE and Winter Madness LE, combined with Cure’s positioning and macro execution against Protoss aggression, shape the matchup. The best-of-three format rewards consistent opening execution and adaptation in this high-stakes group environment.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日外部リンクに注意してください。
外部リンクに注意してください。

外部リンクに注意してください。
外部リンクに注意してください。
よくある質問